Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective

A significant amount of attention has recently been devoted to the mechanisms involved in hemoglobin (Hb) switching, as it has previously been established that the induction of fetal hemoglobin (HbF) production in significant amounts can reduce the severity of the clinical course in diseases such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Bou-Fakhredin, Rayan, De Franceschi, Lucia, Motta, Irene, Cappellini, Maria Domenica, Taher, Ali T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227505/
https://www.ncbi.nlm.nih.gov/pubmed/35745672
http://dx.doi.org/10.3390/ph15060753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227505/
https://www.ncbi.nlm.nih.gov/pubmed/35745672
http://dx.doi.org/10.3390/ph15060753

Ejemplares similares